Clinical Trials · NCT07583563
An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- Camurus AB
- Enrollment
- 200
- Start date
- Jun 2026
- Locations
- 5 sites, Germany
- Primary endpoint
- Incidence of octreotide SC depot-related AEs and SAEs during 2 years of treatment. Focus is on related AESIs and Other Safety Information.